Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Venom Peptides Across Asian and American Tarantulas Utilize Dual Pharmacology to Target Activation and Fast Inactivation of Voltage-Gated Sodium Channels. | Toxins (Basel) | 2025 | 41295876 | PubTator, text mining | PubMed |
| Position-dependent effects of SCN2A premature stop codons on neuronal excitability and behavior. | bioRxiv | 2025 | 41279287 | PubTator, text mining | PubMed |
| CRISPR-engineered deletion of POGZ alters transcription factor binding at promoters of genes involved in synaptic signaling. | bioRxiv | 2025 | 41279137 | PubTator, text mining | PubMed |
| Large-scale discovery of neural enhancers for cis-regulation therapies. | bioRxiv | 2025 | 41278953 | PubTator, text mining | PubMed |
| RNA-based therapies for neurodevelopmental disorders: innovative tools for molecular correction. | Front Mol Biosci | 2025 | 41244709 | PubTator, text mining | PubMed |
| Molecular interactions of the NaV1.5 C-terminal domain: CaM sequestered the IQ motif from the CTD. | J Biol Chem | 2025 | 41173394 | PubTator, text mining | PubMed |
| Genetic Etiology of Developmental and Epileptic Encephalopathy in a Turkish Cohort: A Single-Center Study with Targeted Gene Panel and Whole Exome Sequencing. | Genes (Basel) | 2025 | 41153369 | PubTator, text mining | PubMed |
| The Greek Versions of the HLS19 Health Literacy Instruments (HLS19-NAV-GR, HLS19-COM-GR, and HLS19-VAC-GR): Translation, Cultural Adaptation, and Descriptive Pilot Evaluation. | Healthcare (Basel) | 2025 | 41095626 | PubTator, text mining | PubMed |
| FGF14 Peptide Derivative Differentially Regulates Nav1.2 and Nav1.6 Function. | Life (Basel) | 2025 | 41010287 | PubTator, text mining | PubMed |
| Effects of dibenzazepine compounds on Nav1.2 channels and neuronal network activity: A systematic comparison. | Eur J Pharmacol | 2025 | 40946950 | PubTator, text mining | PubMed |
| One-Step Drug Screening System Utilizing Electrophysiological Activity in Multiple Brain Organoids. | Adv Sci (Weinh) | 2025 | 40940692 | PubTator, text mining | PubMed |
| Cohort Tracking of Sickle Cell Trait-Positive Births Identified by Newborn Screening, California, 1991-2013: Public Health Surveillance for Sickle Cell Trait. | Public Health Rep | 2025 | 40932173 | PubTator, text mining | PubMed |
| Noncoding de novo mutations in SCN2A are associated with autism spectrum disorders. | iScience | 2025 | 40894881 | PubTator, text mining | PubMed |
| Epilepsy-Associated SCN2A-L1342P Mutation Drives Network Hyperexcitability and Widespread Transcriptomic Changes in Human Cortical Organoids. | bioRxiv | 2025 | 40894722 | PubTator, text mining | PubMed |
| Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction. | Epilepsia | 2025 | 40884529 | PubTator, text mining | PubMed |
Neutrophil gelatinase-associated lipocalin and fibrinogen-to-albumin ratio are indicators of kidney disease in sickle cell disease patients with microalbuminuria: a multicentre case-control study in Ghana. | BMC Nephrol | 2025 | 40883664 | PubTator, text mining | PubMed |
| Saltatory axonal conduction in the avian retina. | J Physiol | 2025 | 40880505 | PubTator, text mining | PubMed |
| Calpain in Traumatic Brain Injury: From Cinderella to Central Player. | Cells | 2025 | 40862734 | PubTator, text mining | PubMed |
| Microglial activation is inhibited by selective anti-seizure medications. | Inflamm Res | 2025 | 40848130 | PubTator, text mining | PubMed |
| Evaluation of familial phenotype deviation to measure the impact of de novo mutations in autism. | Genome Med | 2025 | 40836247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers?page=7